Client & Alumni News

OraSure Technologies Awarded $16.6M for Rapid Zika Tests

OraSure Technologies, Inc. (NASDAQ: OSUR) has been awarded a contract for up to $16.6 million in total funding from the U.S. Department of Health and Human Services to advance its rapid Zika tests. The rapid Zika tests utilize OraSure’s OraQuick® technology platform, which is the same proven technology used in the company’s rapid HIV, HCV, and Ebola test kits. Read more via Lehigh Valley Business and